About Rapport Therapeutics Talent Community
Precision medicines to match the complexity of the human brain.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Boston, Massachusetts
- Founded
- 2022
- Company type
- Privately Held
- Company profile name
- Rapport Therapeutics
Rapport Therapeutics aims to transform the treatment of neurological disorders through a precision medicine approach, precisely targeting disease-driving neurocircuits by leveraging receptor-associated proteins (RAPs). With this approach, Rapport can overcome the well-established limitations of today’s neuromedicines that act indiscriminately throughout the nervous system, resulting in suboptimal efficacy and burdensome side effects. Leading the hunt for precision medicines is a team with established track records of innovation in neuroscience and drug discovery. Rapport was conceptualized and created through a partnership between Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc. (JJDC) and launched in March 2023. Rapport is based in San Diego, CA and Boston, MA. For more information, please visit www.rapportrx.com.
Company locations
Boston, Massachusetts, US
San Diego, California , US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Care
- Biotechnology
- Life Science
- Medical
- Precision Medicine
- Neuroscience
On LinkedIn
- Followers
- 15,960
- People linked to this company
- 103
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
500,000,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.